These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8222284)

  • 1. Genetic and molecular heterogeneity of breast cancer cells.
    Callahan R; Cropp C; Merlo GR; Diella F; Venesio T; Lidereau R; Cappa AP; Lisicia DS
    Clin Chim Acta; 1993 Jul; 217(1):63-73. PubMed ID: 8222284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations and human breast cancer. A status report.
    Callahan R; Cropp CS; Merlo GR; Liscia DS; Cappa AP; Lidereau R
    Cancer; 1992 Mar; 69(6 Suppl):1582-8. PubMed ID: 1540899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
    Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
    Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
    Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
    Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors.
    Callahan R; Cropp C; Sheng ZM; Merlo G; Steeg P; Liscia D; Lidereau R
    J Cell Biochem Suppl; 1993; 17G():167-72. PubMed ID: 8007695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt to define sets of cooperating genetic alterations in human breast cancer.
    Cheickh MB; Rouanet P; Louason G; Jeanteur P; Theillet C
    Int J Cancer; 1992 Jun; 51(4):542-7. PubMed ID: 1351044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity for allelic loss in human breast cancer.
    Chen LC; Kurisu W; Ljung BM; Goldman ES; Moore D; Smith HS
    J Natl Cancer Inst; 1992 Apr; 84(7):506-10. PubMed ID: 1312176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
    Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S
    Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at chromosome 1p in human breast cancer.
    Ragnarsson G; Sigurdsson A; Eiriksdottir G; Barkardottir R; Jonasson J; Ingvarsson S
    Int J Oncol; 1996 Oct; 9(4):731-6. PubMed ID: 21541576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in primary breast cancer.
    Callahan R
    Breast Cancer Res Treat; 1989 Jul; 13(3):191-203. PubMed ID: 2667653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
    Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
    Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in human breast cancer: an overview.
    Callahan R; Campbell G
    J Natl Cancer Inst; 1989 Dec; 81(23):1780-6. PubMed ID: 2685334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
    Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
    Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.